Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Mika Aoyagi"'
Autor:
Mika Aoyagi-Scharber, Danielle Crippen-Harmon, Roger Lawrence, Jon Vincelette, Gouri Yogalingam, Heather Prill, Bryan K. Yip, Brian Baridon, Catherine Vitelli, Amanda Lee, Olivia Gorostiza, Evan G. Adintori, Wesley C. Minto, Jeremy L. Van Vleet, Bridget Yates, Sara Rigney, Terri M. Christianson, Pascale M.N. Tiger, Melanie J. Lo, John Holtzinger, Paul A. Fitzpatrick, Jonathan H. LeBowitz, Sherry Bullens, Brett E. Crawford, Stuart Bunting
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 43-53 (2017)
Sanfilippo syndrome type B (mucopolysaccharidosis IIIB), caused by inherited deficiency of α-N-acetylglucosaminidase (NAGLU), required for lysosomal degradation of heparan sulfate (HS), is a pediatric neurodegenerative disorder with no approved trea
Externí odkaz:
https://doaj.org/article/391415b4d80b4db49263e27fbcc2640a
Autor:
Gouri Yogalingam, Amanda R Luu, Heather Prill, Melanie J Lo, Bryan Yip, John Holtzinger, Terri Christianson, Mika Aoyagi-Scharber, Roger Lawrence, Brett E Crawford, Jonathan H LeBowitz
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0207836 (2019)
Sanfilippo syndrome type B (Sanfilippo B; Mucopolysaccharidosis type IIIB) occurs due to genetic deficiency of lysosomal alpha-N-acetylglucosaminidase (NAGLU) and subsequent lysosomal accumulation of heparan sulfate (HS), which coincides with devasta
Externí odkaz:
https://doaj.org/article/61f67561557e43deb10bf75caf69b046
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200008 (2018)
Given the large and expanding quantity of publicly available sequencing data, it should be possible to extract incidence information for monogenic diseases from allele frequencies, provided one knows which mutations are causal. We tested this idea on
Externí odkaz:
https://doaj.org/article/d386bcf187ea4de08dc067e03e25287f
Autor:
Melanie J. Lo, Heather Prill, Mika Aoyagi-Scharber, Gouri Yogalingam, Terri Christianson, Amanda R. Luu, Roger Lawrence, John Holtzinger, Brett E. Crawford, Bryan K. Yip, Jonathan H. LeBowitz
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0207836 (2019)
PLoS ONE
PLoS ONE
Sanfilippo syndrome type B (Sanfilippo B; Mucopolysaccharidosis type IIIB) occurs due to genetic deficiency of lysosomal alpha-N-acetylglucosaminidase (NAGLU) and subsequent lysosomal accumulation of heparan sulfate (HS), which coincides with devasta
Publikováno v:
JOURNAL OF THE ILLUMINATING ENGINEERING INSTITUTE OF JAPAN. 100:82-86
Autor:
Charles O'Neill, Mika Aoyagi-Scharber, Jukka Poulivali, Sundeep Chandra, Ashley Frazer-Abel, Maria Hedlund, Nicole A. Datson, Andrew Melton, David Jacoby, M Benjamin Hock, Ganesh Cherala, Sylvia Fong, Todd M. Oppeneer, Judith C.T. van Deutekom, Shripad Bhagwat, Xiefan Fang
Publikováno v:
Neuromuscular Disorders. 30:S169
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 7, p e0200008 (2018)
PLoS ONE, Vol 13, Iss 7, p e0200008 (2018)
Given the large and expanding quantity of publicly available sequencing data, it should be possible to extract incidence information for monogenic diseases from allele frequencies, provided one knows which mutations are causal. We tested this idea on
Publikováno v:
Journal of Medicinal Chemistry. 59:335-357
We discovered and developed a novel series of tetrahydropyridophthlazinones as poly(ADP-ribose) polymerase (PARP) 1 and 2 inhibitors. Lead optimization led to the identification of (8S,9R)-47 (talazoparib; BMN 673; (8S,9R)-5-fluoro-8-(4-fluorophenyl)
Autor:
Florence Lorget, Sean M. Bell, Mika Aoyagi-Scharber, Sianna Castillo, William R. Wilcox, Pavel Krejci, Melita Dvorak-Ewell, David L. Rimoin, Jeff Peng, Charles A. O’Neill, Stuart Bunting, Daniel J. Wendt, Sherry Bullens
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 353:132-149
Achondroplasia (ACH), the most common form of human dwarfism, is caused by an activating autosomal dominant mutation in the fibroblast growth factor receptor-3 gene. Genetic overexpression of C-type natriuretic peptide (CNP), a positive regulator of
Autor:
Jeremy L. Van Vleet, Mika Aoyagi-Scharber, Bryan K. Yip, Paul A. Fitzpatrick, Terri Christianson, Olivia Gorostiza, Gouri Yogalingam, Danielle Crippen-Harmon, Stuart Bunting, Heather Prill, Pascale M.N. Tiger, Evan G. Adintori, Sherry Bullens, Jonathan H. LeBowitz, Wesley C. Minto, Catherine Vitelli, Bridget Yates, Brian Baridon, Roger Lawrence, Brett E. Crawford, John Holtzinger, Jon Vincelette, Sara Rigney, Amanda Lee, Melanie J. Lo
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 43-53 (2017)
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 43-53 (2017)
Sanfilippo syndrome type B (mucopolysaccharidosis IIIB), caused by inherited deficiency of α-N-acetylglucosaminidase (NAGLU), required for lysosomal degradation of heparan sulfate (HS), is a pediatric neurodegenerative disorder with no approved trea